Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

The Quick Take
Revenue growth of 27% driven by strong performance in molecular profiling services, including approximately 61,500 clinical cases, consisting of over 358,000 total oncology tests Raises 2026 revenue guidance to $1.04 to $1.05 billion, representing growth of 28% to 29% IRVING, Texas, Nov....
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
BROCO ENERGY AWARDED TWO FIVE-YEAR MASSACHUSETTS STATEWIDE FUEL CONTRACTS
Statewide awards include renewable diesel, biodiesel, heating oil and eligible liquid biofuel for public entities across the Commonwealth. BOSTON, Nov. 4, 2026…
Business
Goldcom earnings missed by $0.88, revenue fell short of estimates
Business
Olin extends receivables purchase agreement termination date to July 2028
Business
